FI853923A7 - Substituoidut propaani- fosfonihappoyhdisteet. - Google Patents

Substituoidut propaani- fosfonihappoyhdisteet. Download PDF

Info

Publication number
FI853923A7
FI853923A7 FI853923A FI853923A FI853923A7 FI 853923 A7 FI853923 A7 FI 853923A7 FI 853923 A FI853923 A FI 853923A FI 853923 A FI853923 A FI 853923A FI 853923 A7 FI853923 A7 FI 853923A7
Authority
FI
Finland
Prior art keywords
phosphonic acid
acid compounds
substituted propane
propane
substituted
Prior art date
Application number
FI853923A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI853923L (fi
FI853923A0 (fi
Inventor
John Grey Dingwall
Roger Graham Hall
James Jack
Josef Ehrenfreund
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI853923A0 publication Critical patent/FI853923A0/fi
Publication of FI853923L publication Critical patent/FI853923L/fi
Publication of FI853923A7 publication Critical patent/FI853923A7/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/48Phosphonous acids [RP(OH)2] including [RHP(=O)(OH)]; Thiophosphonous acids including [RP(SH)2], [RHP(=S)(SH)]; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/30Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/32Esters thereof
    • C07F9/3205Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/3211Esters of acyclic saturated acids which can have further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/48Phosphonous acids [RP(OH)2] including [RHP(=O)(OH)]; Thiophosphonous acids including [RP(SH)2], [RHP(=S)(SH)]; Derivatives thereof
    • C07F9/4808Phosphonous acids [RP(OH)2] including [RHP(=O)(OH)]; Thiophosphonous acids including [RP(SH)2], [RHP(=S)(SH)]; Derivatives thereof the acid moiety containing a substituent or structure which is considered as characteristic
    • C07F9/4816Acyclic saturated acids or derivatices which can have further substituents on alkyl
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Seasonings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
FI853923A 1984-10-12 1985-10-09 Substituoidut propaani- fosfonihappoyhdisteet. FI853923A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848425872A GB8425872D0 (en) 1984-10-12 1984-10-12 Chemical compounds

Publications (3)

Publication Number Publication Date
FI853923A0 FI853923A0 (fi) 1985-10-09
FI853923L FI853923L (fi) 1986-04-13
FI853923A7 true FI853923A7 (fi) 1986-04-13

Family

ID=10568115

Family Applications (1)

Application Number Title Priority Date Filing Date
FI853923A FI853923A7 (fi) 1984-10-12 1985-10-09 Substituoidut propaani- fosfonihappoyhdisteet.

Country Status (16)

Country Link
US (4) US4656298A (enExample)
EP (1) EP0181833B1 (enExample)
JP (1) JPH0631275B2 (enExample)
AT (1) ATE53844T1 (enExample)
CA (1) CA1296736C (enExample)
DE (1) DE3577442D1 (enExample)
DK (2) DK168572C (enExample)
ES (1) ES8800250A1 (enExample)
FI (1) FI853923A7 (enExample)
GB (1) GB8425872D0 (enExample)
GR (1) GR852451B (enExample)
IE (1) IE58142B1 (enExample)
IL (1) IL76625A0 (enExample)
NO (1) NO854045L (enExample)
PT (1) PT81287B (enExample)
ZA (1) ZA857824B (enExample)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5457095A (en) * 1984-10-12 1995-10-10 Ciba-Geigy Corporation Substituted propane-phosponous acid compounds
US5243062A (en) * 1984-10-12 1993-09-07 Ciba-Geigy Corporation Substituted propane-phosphonous acid compounds
US4761405A (en) * 1987-03-04 1988-08-02 Nova Pharmaceutical Corporation Antagonists of specific excitatory amino acid neurotransmitter receptors having increased potency
GB8721442D0 (en) * 1987-09-11 1987-10-21 Ciba Geigy Ag Process
GB8728483D0 (en) * 1987-12-04 1988-01-13 Ciba Geigy Ag Chemical compounds
US5190933A (en) * 1987-12-04 1993-03-02 Ciba-Geigy Corporation Substituted propane-phosphinic acid compounds
US5300679A (en) * 1987-12-04 1994-04-05 Ciba-Geigy Corporation Substituted propane-phosphinic acid compounds
GB8820266D0 (en) * 1988-08-26 1988-09-28 Smith Kline French Lab Compounds
US5567840A (en) * 1989-05-13 1996-10-22 Ciba-Geigy Corporation Substituted aminoalkylphosphinic acids
US5281747A (en) * 1989-05-13 1994-01-25 Ciba-Geigy Corporation Substituted aminoalkylphosphinic acids
US5190934A (en) * 1989-06-03 1993-03-02 Ciba-Geigy Corporation P-subsituted propane-phosphinic acid compounds
IL98502A (en) * 1990-06-22 1998-04-05 Ciba Geigy Ag Aminoalkane phosphinic acid derivatives, process for their preparation and pharmaceutical compositions containing them
EP0767174A1 (de) * 1991-11-21 1997-04-09 Ciba-Geigy Ag Neue Aminoalkanphosphinsäuren und ihre Salze
GB9125615D0 (en) * 1991-12-02 1992-01-29 Wyeth John & Brother Ltd Amines
AU662404B2 (en) * 1992-05-08 1995-08-31 Novartis Ag Novel N-aralkyl- and N-heteroaralkyl-aminoalkanephosphinic acids
GB9304619D0 (en) * 1993-03-06 1993-04-21 Ciba Geigy Ag Esters
IL126999A (en) 1996-07-24 2002-03-10 Warner Lambert Co Pharmaceutical preparations containing isobutylgaba and its history for use in the treatment of pain
US6753324B2 (en) * 1998-07-15 2004-06-22 Hassan Jomaa Phosphorous organic compounds and their use
SE9904508D0 (sv) 1999-12-09 1999-12-09 Astra Ab New compounds
US7319095B2 (en) 1999-12-09 2008-01-15 Astrazeneca Ab Use of GABAB receptor agonists
SE9904507D0 (sv) 1999-12-09 1999-12-09 Astra Ab New compounds
BR0017170A (pt) * 2000-03-20 2003-11-04 Francois Bernard Aparelho de lançamento para lançar um objeto em um fluido, clipe, navio, e, método para lançar uma carga em um fluido
US7184014B2 (en) * 2000-10-05 2007-02-27 Semiconductor Energy Laboratory Co., Ltd. Liquid crystal display device
AR033779A1 (es) 2001-06-08 2004-01-07 Astrazeneca Ab Compuestos utiles en la enfermedad de reflujo
CA2477423A1 (en) 2002-03-01 2003-09-12 Merck & Co., Inc. Aminoalkylphosphonates and related compounds as edg receptor agonists
US7195806B2 (en) * 2003-01-17 2007-03-27 Fina Technology, Inc. High gloss polyethylene articles
DE10356410A1 (de) * 2003-11-24 2005-06-23 Bioagency Ag Phosphororganische Verbindungen und deren Verwendung
US20050176680A1 (en) 2003-12-11 2005-08-11 Sepracor, Inc. Combination of sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
SE0401653D0 (sv) 2004-06-24 2004-06-24 Astrazeneca Ab New compounds
WO2006050472A2 (en) * 2004-11-03 2006-05-11 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs of 3-aminopropylphosphonous and -phosphinic acids
US7566738B2 (en) * 2004-11-03 2009-07-28 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs of sulfinic acids, methods of synthesis, and use
EP2275096A3 (en) 2005-08-26 2011-07-13 Braincells, Inc. Neurogenesis via modulation of the muscarinic receptors
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
AU2006304787A1 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by PDE inhibition
CA2625210A1 (en) * 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US7745474B2 (en) 2005-12-23 2010-06-29 Astrazeneca Ab Imidazole derivatives for the treatment of gastrointestinal disorders
AU2006327317B2 (en) 2005-12-23 2010-11-25 Astrazeneca Ab GABA-B receptor modulators
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
AU2007249399A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
AU2007249435A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. 5 HT receptor mediated neurogenesis
BRPI0716604A2 (pt) 2006-09-08 2013-04-09 Braincells Inc combinaÇÕes contendo um derivado de 4-acilaminopiridina
US7585996B2 (en) * 2006-09-15 2009-09-08 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
WO2011113904A1 (en) 2010-03-17 2011-09-22 INSERM (Institut National de la Santé et de la Recherche Médicale) Medicaments for the prevention and treatment of a disease associated with retinal ganglion cell degeneration
DK2621282T3 (da) 2010-09-28 2020-05-04 Univ California Gaba-agonister i behandlingen af forstyrrelser forbundet med metabolisk syndrom og gaba-kombinationer i behandling eller profylakse af type i diabetes
CN102718717B (zh) * 2012-06-15 2015-03-11 河北鑫淘源环保科技有限公司 一种固体1,3-二羟甲基-5,5-二甲基海因的烘干方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2535175A (en) * 1949-05-11 1950-12-26 Us Rubber Co Nitroalkanephosphonates
US3374288A (en) * 1965-09-03 1968-03-19 Du Pont Polycarbonamide filaments containing polyalkylene oxide, sodium phenyl phosphinate and sodium aminoalkylphosphinate
US3385822A (en) * 1967-07-03 1968-05-28 Gen Electric Moisture curable polysiloxane phosphate composition
US3784590A (en) * 1969-01-02 1974-01-08 Merck & Co Inc Hydroxy and imino containing phosphonic acid diesters
US3637763A (en) * 1969-01-02 1972-01-25 Merck & Co Inc Preparation of (cis-1 2-epoxypropyl) phosphonates from substituted imino compounds
DE2032712C3 (de) * 1970-07-02 1978-10-19 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von w-Amino-alkanphosphonsäure bzw.- phosphinsäurederivaten
SU436675A1 (ru) * 1972-05-03 1974-07-25 Азербайджанский Институт Нефти И Химии Способ приготовлени алюмосиликатного катализатора дл крекинга нефт ных фракций
SU463675A1 (ru) * 1973-12-04 1975-03-15 Казанский Химико-Технологический Институт Им.С.М.Кирова Способ получени -фосфорилированных нитроалканолов
DE2424243A1 (de) * 1974-05-18 1975-11-27 Bayer Ag Perfluoralkansulfonamidoalkanphosphonsaeure- bzw. -phosphinsaeurederivate
US4339443A (en) * 1978-09-22 1982-07-13 Fbc Limited Compounds and compositions
US4390690A (en) * 1979-07-24 1983-06-28 Occidental Research Corp. Layered organophosphorous inorganic polymers containing oxygen bonded to carbon
ATE11918T1 (de) * 1979-12-08 1985-03-15 Fbc Ltd 4-(methylphosphinyl)-2-oxobuttersaeure-derivate, sie enthaltende herbizide zusammensetzungen und zwischenprodukte und verfahren zu ihrer herstellung.
US4466913A (en) * 1981-06-30 1984-08-21 Maiji Seika Kaisha Ltd. Phosphorus-containing compounds and process for producing the same
US4386013A (en) * 1981-08-24 1983-05-31 Occidental Research Corporation Hydroformylation process utilizing novel catalyst
DE3362581D1 (en) * 1982-04-23 1986-04-24 Ciba Geigy Ag Herbicide and plant-growth regulator product
SU1174439A1 (ru) * 1984-06-28 1985-08-23 МГУ им.М.В.Ломоносова Способ получени @ -алкил- @ -триметилсилил(диалкоксиметил)фосфонитов
US4740332A (en) * 1986-05-12 1988-04-26 E. R. Squibb & Sons, Inc. Process for preparing phosphonous acids
JPS6451592A (en) * 1987-08-21 1989-02-27 Matsushita Electric Industrial Co Ltd Character recognizing device

Also Published As

Publication number Publication date
GB8425872D0 (en) 1984-11-21
EP0181833A1 (en) 1986-05-21
PT81287B (pt) 1988-02-17
JPH0631275B2 (ja) 1994-04-27
DK81093A (da) 1993-07-06
JPS6193189A (ja) 1986-05-12
US5004826A (en) 1991-04-02
IE852512L (en) 1986-04-12
ES547795A0 (es) 1987-10-16
ATE53844T1 (de) 1990-06-15
DE3577442D1 (de) 1990-06-07
AU4857985A (en) 1986-04-24
ZA857824B (en) 1986-05-28
FI853923L (fi) 1986-04-13
US4656298A (en) 1987-04-07
US4908465A (en) 1990-03-13
FI853923A0 (fi) 1985-10-09
DK168572B1 (da) 1986-04-13
US4772738A (en) 1988-09-20
NO854045L (no) 1986-04-14
EP0181833B1 (en) 1990-05-02
IL76625A0 (en) 1986-02-28
PT81287A (en) 1985-11-01
ES8800250A1 (es) 1987-10-16
GR852451B (enExample) 1986-02-11
DK169626B1 (da) 1994-12-27
CA1296736C (en) 1992-03-03
AU593778B2 (en) 1990-02-22
DK466185D0 (da) 1985-10-11
IE58142B1 (en) 1993-07-14
DK81093D0 (da) 1993-07-06
DK168572C (da) 1994-04-25
DK466185A (da) 1986-04-13

Similar Documents

Publication Publication Date Title
FI853923A7 (fi) Substituoidut propaani- fosfonihappoyhdisteet.
DE3583287D1 (de) Substituierte isochinolinsulfonyl-verbindungen.
FI853313A0 (fi) Speciallins foer glasoegon.
FI840927L (fi) Fixeringsanordning foer faergaemne i en kopieringsmaskin.
FI850140A7 (fi) Kemiallisia yhdisteitä.
FI853736A7 (fi) Triatsolokinatsoliiniyhdisteet.
FI843385L (fi) Anordning i virvelbaeddsreaktor.
FI854811A7 (fi) Skaerhuvud foer traodkapare.
FI854930L (fi) Hyaluronsyra/hyaluronsyrabaserade parfymprodukter.
FI850085L (fi) Aendaggregat foer extrusionsmunstycket i en plastpelleteringsanordning.
FI845087L (fi) Faestuppstaellning foer en skaerkonstruktion i en motorsaog.
FI852768A7 (fi) Yhdisteet.
NO853435L (no) Substituerte 7-oksomitosaner.
DK437685D0 (da) 1alfa,25-dihydroxy-22z-dehydrovitamin d forbindelser
ATE33643T1 (de) 2-bromo-4-methylimidazol-5-carbonsaeureester.
FI854985L (fi) Foerfarande foer framstaellning av farmaceutiskt aktiva n-substituerade aziridin-2-karboxylsyraderivat.
DE3581042D1 (de) Fungizide substituierte 2-aminopropensaeure-derivate.
FI853005A7 (fi) Uudet aminoalkyylipenem-yhdisteet.
FI854619A7 (fi) Kemiallisia yhdisteitä.
FI842050A0 (fi) Banformningsparti i pappersmaskin.
FI842051A7 (fi) Daempningsventil foer kopplingen i en traktors kraftoeverfoeringsaxel.
FI854369A0 (fi) Styranordning foer plasmagenerator.
FI850203A0 (fi) Anordning i maxtermostat foer kombinationspanna.
FI843081A0 (fi) Dubbelviraformare i pappersmaskin.
FI841373A0 (fi) Broms foer fordon.

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: CIBA-GEIGY AG